AARTIIND
Aarti Industries (AARTIIND)
Latest view
Constructive
as of 16 Jun 2026 · not a recommendation
Evidence timeline
What management said
from NSE earnings-call filings · extracted, not interpreted
Call 11-May-2026 · transcript PDF
Outlook, as stated
In addition to that, in the next quarter, which is Q4 of FY '26, we are also planning to commission a slightly increased capacity of MMA based on the debottlenecking effort and in addition to that, one specific molecule PEDA, again, which will become a form of MPP.
FY26-27 begins with sort of cautious optimism supported by improved capacity utilization, strong order visibility through long-term contracts and continue to progress on the key growth and integration initiatives.
Our future performance will be steered by key strategic pillars: ● Successful foray in high-value and advanced chemistries, with commissioning targeted in a phased manner from H2 FY26 at Zone IV.
2.75
concrete references per 100 words spoken — counts, currency, units and
named periods, not adjectives
Chart exhibits
as drawn · not updated since
No forward scenario
the call carried no figure that bridges to earnings growth.
Price chart
260 sessions to 31 Jul 2026 ·
daily close ·
our own broker data